EXHIBIT 1
Joint Filing Agreement
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as
amended, each of the persons named below agrees to the joint filing of a
Statement on Schedule 13D (including amendments thereto) with respect to the
common stock, par value $0.001 per share, of Idenix Pharmaceuticals, Inc., a
Delaware corporation.
Date: September 2, 2005
NOVARTIS AG
By: /s/ Xxxxxx Xxxxxx
----------------------------------
Name: Xxxxxx Xxxxxx
Title: Authorized Signatory
By: /s/ Xxxxx Xxxxxxxxx
----------------------------------
Name: Xxxxx Xxxxxxxxx
Title: Authorized Signatory
NOVARTIS PHARMA AG
By: /s/ Xxxxxx X. Xxxxxx
----------------------------------
Name: Xxxxxx X. Xxxxxx
Title: General Counsel
By: /s/ Xxxxxx X. Xxxxx
----------------------------------
Name: Xxxxxx X. Xxxxx
Title: Head Operational Treasury
NOVARTIS BIOVENTURES LTD.
By: /s/ Xxxx Xxxx
----------------------------------
Name: Xxxx Xxxx
Title: Member of the Board
of Directors
Page 12 of 12